Form 4: Arvinas Director Sunil Agarwal Reports Changes in Beneficial Ownership

Director Sunil Agarwal reports acquisition and disposal of Arvinas, Inc. common stock and stock options.

Summary

• On May 29, 2024, Director Sunil Agarwal reported changes in beneficial ownership of Arvinas, Inc. securities.
• Agarwal acquired 5,899 shares of common stock through restricted stock units (RSUs) at $0.
• Agarwal disposed of 14,141 shares of common stock.
• Agarwal was granted a stock option to purchase 9,070 shares of common stock at an exercise price of $33.90.
• The RSUs and stock options vest on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
• Agarwal also provided a Limited Power of Attorney for Section 16 reporting obligations, effective May 30, 2024, appointing John Houston, Randy Teel, Jared Freedberg, and Christina Bailey as attorneys-in-fact.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The grant of RSUs and stock options to a director could be seen as an incentive to align their interests with those of the shareholders.

Negatives

• The disposal of 14,141 shares by a director could be interpreted negatively by some investors, although the reason for disposal is not specified.

Risks

• The vesting of RSUs and stock options is contingent upon continued service or the occurrence of specific events, which introduces a degree of uncertainty.

Future Outlook

The vesting of the RSUs and stock options is contingent on future events, specifically continued service until May 29, 2025, or the first board meeting after the next annual stockholder meeting.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's confidence in the company's prospects.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders, ensuring transparency in stock ownership and transactions.
• The vesting schedules for RSUs and stock options are typical, often tied to continued employment or specific performance milestones, similar to practices at companies like Amgen and Gilead.

Stakeholder Impact

• Shareholders may be interested in the director's transactions as an indicator of confidence in the company.
• The filing ensures transparency and compliance with SEC regulations.

Key Dates